Abstract
BACKGROUND: Despite the leading role of HLA markers in genetic susceptibility to type 1 diabetes (T1D), their prognostic value for individual risk assessment remains limited. The role of autoantibody status as a mediating or independent factor in the association between HLA markers and the risk of T1D in children is still insufficiently studied. AIM:To evaluate the role of islet autoantibody status as a mediating factor in the association between HLA markers and the risk of T1Din children. METHODS:The study included 423 participants: 257 patients aged 0–17 years with newly diagnosed T1D and 166 of their healthy biological siblings. The median age in both groups was 8 years, and males accounted for 58% of participants. All individuals were tested for islet autoantibodies (GADA, IA-2A, IAA, ZnT8A, ICA) and underwent HLA genotyping of HLA-A, -B, -C, -DR, -DQ, and -DP alleles. Blood samples were collected within 1–2 days of hospital admission in patients with T1D and on an outpatient basis in healthy siblings. RESULTS:Patients with T1D exhibited a higher frequency and higher levels of islet autoantibodies, particularly ZnT8A, IA-2A, and GADA. Classical high-risk haplotypes DR3–DQ2 and DR4–DQ8 predominated in the T1D group. The HLA-B*08:01 allele and the DRB1*08:01–DQA1*04:01–DQB1*04:02 haplotype were more common in patients with T1D, whereas the DPB1*04:02 allele was characteristic of healthy siblings. Multivariable models demonstrated that some HLA markers were associated with T1D risk independently of autoantibody status, while other effects were predominantly mediated by autoimmune activity. CONCLUSION:The combined assessment of HLA genetic markers and autoantibody status provides a more comprehensive characterization of preclinical immunogenetic pathways involved in the development of T1D in children and may improve the effectiveness of early screening.

This publication has 13 references indexed in Scilit: